Edition:
United Kingdom

Intersect ENT Inc (XENT.OQ)

XENT.OQ on NASDAQ Stock Exchange Global Market

36.90USD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
$36.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
59,621
52-wk High
$38.20
52-wk Low
$12.52

Select another date:

Mon, Jan 8 2018

BRIEF-Intersect ENT Reports Preliminary Q4 And Year 2017 Revenue

* - CO CONTINUES TO EXPECT TO LAUNCH SINUVA COMMERCIALLY IN Q2 OF 2018

BRIEF-‍James Flynn​ reports 5.92 pct passive stake in Intersect ENT

* ‍James Flynn​ reports 5.92 percent passive stake in Intersect ENT as of Nov 6 - SEC filing Source text : (http://bit.ly/2jwmJXW) Further company coverage:

BRIEF-FDA performs pre-approval inspection of Intersect ENT's menlo park facility

* FDA performs pre-approval inspection of Intersect ENT's menlo park facility

BRIEF-Intersect ENT Inc reports Q3 revenue $22.3 million

* Intersect ENT Inc - ‍outlook for 2017 gross margin continues to be about 84%​

Select another date: